CERC's drug is anti-TNF only. Which TNF is an impo
Post# of 148170
(Total Views: 447)
Posted On: 03/02/2021 9:21:46 PM
CERC's drug is anti-TNF only. Which TNF is an important one in COVID and one that leronlimab downregulates. They certainly chose the right inclusion/exclusion criteria which fits mild to moderate and endpoint (alive and free of respiratory failure). Anti-TNF only for severe or above would almost certainly not been enough.
Under that criteria for CD10 leronlimab should have blown the numbers out of the water. With CERC-02 just barely meeting statistical significance and 83 patients their EUA filing is a bit premature.
Under that criteria for CD10 leronlimab should have blown the numbers out of the water. With CERC-02 just barely meeting statistical significance and 83 patients their EUA filing is a bit premature.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼